Approved Formulary
Add Formweb to your mobile device
Approved Formulary
HIGH ALERT: Please read the COMMENTS very carefully.
Do Not Crush
Search results for:
OXYCODONE
OXYCODONE
| Drug Name | Form | Strength | Non-Formulary | Notes |
|---|---|---|---|---|
| ROXICODONE | SOLUTION | 5 MG/5 ML | ||
| OXYDOSE | SOLUTION | 20 MG/ML | ||
| OXYFAST | SOLUTION | 20 MG/ML | ||
| ROXICODONE | TABLET | 5 mg | ||
| ROXOCODONE | TABLET | 15 MG | ||
| ROXOCODONE | TABLET | 30 MG | ||
| OXYCONTIN | TABLET, EXTENDED RELEASE | 10 mg | ||
| OXYCONTIN | TABLET, EXTENDED RELEASE | 20 mg | ||
| OXYCONTIN | TABLET, EXTENDED RELEASE | 40 mg | ||
| OXYCONTIN | TABLET, EXTENDED RELEASE | 80 mg | ||
| OXYCONTIN | TABLET, EXTENDED RELEASE | 100 MG |
View Other Therapeutic Options: Opioid Agonists:
280808
High Alert Drug
Last updated: Apr. 13, 2015
- Do Not Crush
- Black Box Warning: Controlled Release not for prn use
Class II
ISMP recommended Tall Man Letters: oxyCODONE (generic) and OxyCONTIN (extended release brand). "IR" and "CR" should be used to differentiate products.
The High Risk/High Alert Medication Policy may be found by using the search function in Policies and Procedures.
Do not crush extended release tablets (Oxycontin). Doing so may cause a potentially fatal overdose.